The Regulatory Whisperer This week I am talking to Michael Hufford the CEO and Co-Founder of Lygensis a company that is breaking the mold of organ replacement and enabling organ regeneration. They recently received FDA 2A clearance and additional funding and will be starting their first human trials shortly. Michaels background has helped him master the […]
